Andere talen ResMed, Inc.

Aandelen

Beurs gesloten - Nyse Andere beurzen 22:00:01 24-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
213,3 ^USD	+0,79%		-2,43%	+23,97%

23/05	ResMed zegt dat onderzoek effectiviteit aantoont van positieve luchtwegdruktherapie voor slaapapneu	MT
14/05	Transcript : ResMed Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 04:05 PM

ResMed : Third Quarter 2024 Transcript	23/05
ResMed Says Research Shows Effectiveness of Positive Airway Pressure Therapy For Sleep Apnea	23/05
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy	23/05
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy	16/05
Resmed Insider Sold Shares Worth $2,747,810, According to a Recent SEC Filing	10/05
Resmed Insider Sold Shares Worth $3,178,815, According to a Recent SEC Filing	09/05
ResMed Announces Participation in the RBCCM Global Healthcare Conference	07/05
ResMed : Q3 2024 ResMed Earnings Results Webcast Transcript	30/04
Morgans rates RMD as Add	29/04
ResMed Silences The Doubters	29/04
Sector Update: Health Care Stocks Edge Higher Late Afternoon	26/04
Top Midday Gainers	26/04
Sector Update: Health Care Stocks Higher in Afternoon Trading	26/04
In-Line Inflation Data, Tech Earnings Lift US Equity Indexes	26/04
Sector Update: Health Care	26/04
ResMed's Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Up Over 17%	26/04
ResMed Declares Quarterly Dividend as Fiscal Q3 Profit Jumps 29%; Shares Up 7%	26/04
ResMed tops quarterly profit estimates on strong demand for sleep apnea devices	26/04
ResMed : Q3 2024 ResMed Earnings Results Webcast Corporate 1-Pager	26/04
ResMed : Q3 2024 ResMed Earnings Results Webcast Presentation	26/04

Geen resultaten voor deze zoekopdracht